PPARs AGONIST ACTIVITY ENHANCING DRUG
    1.
    发明申请
    PPARs AGONIST ACTIVITY ENHANCING DRUG 有权
    PPARs AGONIST活动增强药物

    公开(公告)号:US20160374986A1

    公开(公告)日:2016-12-29

    申请号:US15260434

    申请日:2016-09-09

    发明人: Munekazu Iinuma

    IPC分类号: A61K31/366 A61K9/00

    摘要: A lifestyle disease improving drug is disclosed that enhances PPARα, δ and γ agonist activities that includes a compound having the lactone structure in accordance with the chemical formula 6-alkyl-5,6-dihydro-2H-pyran-2-one, the alkyl containing 4, 5, or 6 carbons. Methods for enhancing PPARα, γ and δ agonist activities in vertebrates or medically treating a vertebrate are disclosed. The methods include providing a composition of an active ingredient, the lifestyle disease improving drug, in a biologically acceptable medium and administering an effective amount of the composition to a vertebrate.

    摘要翻译: 公开了一种生活方式改善药物,其增强PPARα,δ和γ激动剂活性,其包括具有根据化学式6-烷基-5,6-二氢-2H-吡喃-2-酮的内酯结构的化合物,烷基 含有4个,5个或6个碳。 公开了增强脊椎动物中PPARα,γ和δ激动剂活性或医学治疗脊椎动物的方法。 所述方法包括在生物可接受的培养基中提供活性成分的组合物,生活方式改善药物,并向脊椎动物施用有效量的组合物。

    PPARs AGONIST ACTIVITY ENHANCING DRUG
    2.
    发明申请
    PPARs AGONIST ACTIVITY ENHANCING DRUG 审中-公开
    PPARs AGONIST活动增强药物

    公开(公告)号:US20150087846A1

    公开(公告)日:2015-03-26

    申请号:US14388012

    申请日:2013-03-21

    发明人: Munekazu Iinuma

    IPC分类号: C07D309/32

    摘要: A lifestyle disease improving drug that enhances PPARα, δ and γ agonist activities that includes a compound having the lactone structure in accordance with the chemical formula 6-alkyl-5,6-dihydro-2H-pyran-2-one, the alkyl containing 4, 5, or 6 carbons, and a method for synthesizing the compound. The method includes adding, stepwise, a butyllithium-hexane solution to a diisopropylamine-tetrahydrofuran solution, and then a 6-alkyltetrahydro-2H-pyran-2-one-tetrahydrofuran solution, wherein the alkyl contains 4, 5, or 6 carbons, adding a phenylselenyl choloride-tetrahydrofuran solution to produce a reaction mixture with a phenylselenide, extracting and purifying the phenylselenide, preparing a phenylselenide-tetrahydrofuran solution with the purified phenylselenide, and adding sodium bicarbonate and an aqueous hydrogen peroxide solution to the phenylselenide-tetrahydrofuran solution to produce a reaction mixture including the compound.

    摘要翻译: 一种增强PPARα,δ和γ激动剂活性的生活方式改善药物,其包括具有根据化学式6-烷基-5,6-二氢-2H-吡喃-2-酮的内酯结构的化合物,含有4个 ,5或6个碳原子,以及合成该化合物的方法。 该方法包括将丁基锂 - 己烷溶液逐步加入到二异丙胺 - 四氢呋喃溶液中,然后加入6-烷基四氢-2H-吡喃-2-酮 - 四氢呋喃溶液,其中烷基含有4,5或6个碳,加入 苯基烯基氯化物 - 四氢呋喃溶液,以产生与苯基硒化物的反应混合物,萃取和纯化苯基硒化物,用纯化的苯基硒化物制备苯基硒化物 - 四氢呋喃溶液,并将碳酸氢钠和过氧化氢水溶液加入到苯基硒化物 - 四氢呋喃溶液中以产生 包括该化合物的反应混合物。

    PPARs agonist activity enhancing drug

    公开(公告)号:US09999612B2

    公开(公告)日:2018-06-19

    申请号:US15260434

    申请日:2016-09-09

    发明人: Munekazu Iinuma

    摘要: A lifestyle disease improving drug is disclosed that enhances PPARα, δ and γ agonist activities that includes a compound having the lactone structure in accordance with the chemical formula 6-alkyl-5,6-dihydro-2H-pyran-2-one, the alkyl containing 4, 5, or 6 carbons. Methods for enhancing PPARα, γ and δ agonist activities in vertebrates or medically treating a vertebrate are disclosed. The methods include providing a composition of an active ingredient, the lifestyle disease improving drug, in a biologically acceptable medium and administering an effective amount of the composition to a vertebrate.

    PPARs AGONIST ACTIVITY ENHANCING DRUG
    4.
    发明申请
    PPARs AGONIST ACTIVITY ENHANCING DRUG 审中-公开
    PPARs AGONIST活动增强药物

    公开(公告)号:US20160024041A1

    公开(公告)日:2016-01-28

    申请号:US14814013

    申请日:2015-07-30

    发明人: Munekazu Iinuma

    IPC分类号: C07D309/32

    摘要: A lifestyle disease improving drug that enhances PPARα, δ and γ agonist activities that includes a compound having the lactone structure in accordance with the chemical formula 6-alkyl-5,6-dihydro-2H-pyran-2-one, the alkyl containing 4, 5, or 6 carbons.

    摘要翻译: 一种增强PPARα,δ和γ激动剂活性的生活方式改善药物,其包括具有根据化学式6-烷基-5,6-二氢-2H-吡喃-2-酮的内酯结构的化合物,含有4个 ,5或6个碳。